{"id":1345,"date":"2025-06-20T23:55:36","date_gmt":"2025-06-20T23:55:36","guid":{"rendered":"https:\/\/medaxis.com\/blane-sanders-promoted-to-chief-product-and-marketing-officer"},"modified":"2025-09-08T20:29:32","modified_gmt":"2025-09-08T20:29:32","slug":"blane-sanders-promoted-to-chief-product-and-marketing-officer","status":"publish","type":"post","link":"https:\/\/medaxis.com\/fr\/blane-sanders-promoted-to-chief-product-and-marketing-officer","title":{"rendered":"Blane Sanders promu au poste de directeur des produits et du marketing"},"content":{"rendered":"\n
\n
\n \n
\n \n

\n Blane Sanders promu au poste de directeur des produits et du marketing <\/h2>\n \n
\n

Medaxis, a leader in advanced wound care technologies, is pleased to announce the promotion of Blane Sanders<\/a> to Chief Marketing and Product Officer. In this expanded executive role, Sanders will lead global marketing, product innovation, and portfolio strategy as Medaxis accelerates its growth and impact in the wound care market.<\/p>\n

With more than 20 years of medical device leadership experience, Sanders has held key roles at KCI\/3M and Medline, where he helped shape the commercialization of negative pressure wound therapy (NPWT) and other advanced wound healing technologies. Since joining Medaxis, Sanders has played a critical role in advancing product development and bringing new therapies to market.<\/p>\n

\u201cBlane\u2019s deep understanding of the wound care landscape, combined with his strategic vision and relentless focus on execution, makes him the ideal leader to guide our marketing and product strategy,\u201d said Jeffrey Castillo<\/a>, Chief Executive Officer at Medaxis. \u201cThis promotion reflects both his contributions and our commitment to advancing innovation that truly matters to patients and clinicians alike.\u201d<\/p>\n

In his new capacity, Sanders will focus on accelerating the Medaxis product pipeline, deepening clinician partnerships, and expanding the company\u2019s reach in key markets across the globe.<\/p>\n

\u201cIt\u2019s a privilege to step into this role during such a transformative period for Medaxis,\u201d said Sanders. \u201cWe have a mission-driven team, an expanding portfolio, and a clear vision to redefine what\u2019s possible in wound therapy. I\u2019m excited to help lead the next chapter of growth.\u201d<\/p>\n <\/div>\n \n <\/div>\n <\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":1134,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"inline_featured_image":false,"footnotes":""},"categories":[15],"tags":[],"class_list":["post-1345","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-categorise"],"acf":[],"_links":{"self":[{"href":"https:\/\/medaxis.com\/fr\/wp-json\/wp\/v2\/posts\/1345","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medaxis.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medaxis.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medaxis.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medaxis.com\/fr\/wp-json\/wp\/v2\/comments?post=1345"}],"version-history":[{"count":0,"href":"https:\/\/medaxis.com\/fr\/wp-json\/wp\/v2\/posts\/1345\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medaxis.com\/fr\/wp-json\/wp\/v2\/media\/1134"}],"wp:attachment":[{"href":"https:\/\/medaxis.com\/fr\/wp-json\/wp\/v2\/media?parent=1345"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medaxis.com\/fr\/wp-json\/wp\/v2\/categories?post=1345"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medaxis.com\/fr\/wp-json\/wp\/v2\/tags?post=1345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}